Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
57.15
-0.48 (-0.83%)
At close: Jul 11, 2025, 4:00 PM
57.03
-0.12 (-0.21%)
After-hours: Jul 11, 2025, 6:23 PM EDT
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of $7.04 billion as of July 11, 2025. Its market cap has increased by 6.28% in one year.
Market Cap
7.04B
Enterprise Value
7.83B
1-Year Change
6.28%
Ranking
Category
Stock Price
$57.15
Market Cap Chart
Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $7.04B, an increase of 86,839.26%. That is a compound annual growth rate of 37.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 7.10B | 16.74% |
| Dec 31, 2024 | 6.08B | 24.59% |
| Dec 29, 2023 | 4.88B | -36.54% |
| Dec 30, 2022 | 7.69B | 35.91% |
| Dec 31, 2021 | 5.66B | -1.95% |
| Dec 31, 2020 | 5.77B | 122.23% |
| Dec 31, 2019 | 2.60B | 22.85% |
| Dec 31, 2018 | 2.11B | -26.67% |
| Dec 29, 2017 | 2.88B | 125.43% |
| Dec 30, 2016 | 1.28B | -42.33% |
| Dec 31, 2015 | 2.22B | 83.35% |
| Dec 31, 2014 | 1.21B | -29.21% |
| Dec 31, 2013 | 1.71B | 126.01% |
| Dec 31, 2012 | 756.30M | -23.30% |
| Dec 30, 2011 | 986.10M | 23.98% |
| Dec 31, 2010 | 795.40M | 47.84% |
| Dec 31, 2009 | 538.00M | 17.96% |
| Dec 31, 2008 | 456.10M | -17.36% |
| Dec 31, 2007 | 551.90M | 6.38% |
| Dec 29, 2006 | 518.80M | 469.48% |
| Dec 30, 2005 | 91.10M | -13.07% |
| Dec 31, 2004 | 104.80M | 1,193.83% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.95B |
| Johnson & Johnson | 374.60B |
| AbbVie | 335.78B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 274.57B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 217.48B |